Matching slides 118,578
Current window 100,441-100,470
Pages 3,953
Rows per page 30
Component: Paragraphclear collectionreset all

Component

100,441-100,470 of 118,578

filter-aware
06
Innovid | Investor Day Presentation Deck | 74 slidesInnovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Team1 hit
08
The slide uses a stylized global network map background to emphasize global reach.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Loop · Golden Circle1 hit
12
Innovid | Investor Day Presentation Deck | 74 slidesInnovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
35
Innovid | Investor Day Presentation Deck | 74 slidesInnovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
44
The chart illustrates the diversification of revenue away from a single product (Product 1) toward newer products (Product 2 and 3) over time.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
48
The slide uses a comparison structure to link client needs (RFP drivers) to the vendor's value proposition (Why We Won).Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
63
Innovid | Investor Day Presentation Deck | 74 slidesInnovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
66
Chart shows pro forma revenue including TVS acquisition; CAGR calculated using top end of 2023 guidance.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Business Model1 hit
70
Includes non-GAAP financial measure disclaimer.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations 1 hit
10
The slide highlights the 2022 dividend growth and provides a breakdown of the 2022 dividend payment dates.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Call to Adventure1 hit
26
The table compares remuneration structures across two roles and two voting years (2022 AGM vs 2023 AGM).Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
30
The slide outlines the LTI (Long-Term Incentive) structure for the Chairman/CEO and Group Managing Director.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
32
The slide uses a donut chart to visualize the 40/60 split of the €1.4M total remuneration.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
35
The slide uses a 3x3 grid to categorize sustainability priorities. The UN SDG section highlights 13 specific goals.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
44
EP&L stands for Environmental Profit & Loss. The slide uses a bubble matrix to show impact distribution and a line chart for intensity trends.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation1 hit
45
The slide uses a matrix-like structure to map environmental impacts against supply chain stages.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation1 hit
47
The slide uses a consistent framework of reporting 'traceability' and 'alignment with the KS' (Kering Standards) for various raw materials.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation1 hit
56
The slide outlines the SBTN 5-step process and highlights that Kering is involved in the 'Set Targets' phase for Land and Freshwater.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Transformation1 hit
64
The slide uses a grid of six boxes to represent different dimensions of diversity, supported by a governance structure at the bottom.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with ElixirLoop · Jobs To Be Done1 hit
65
The slide uses a donut chart to represent gender diversity metrics.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with ElixirLoop · Jobs To Be Done1 hit
73
The slide outlines a framework for employee well-being consisting of Professional, Social and environmental, Social and personal, and Material dimensions.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with Elixir1 hit
74
Includes a testimonial from Beatrice Lazat and a visual representation of the 'baby leave' policy.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with Elixir1 hit
75
The slide highlights the 2022 launch of the first employee share program.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with Elixir1 hit
78
The slide features a screenshot of a LinkedIn-style post by Francois-Henri Pinault regarding the 'Our Culture of Integrity' campaign.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with Elixir1 hit
79
Kering | ESG Presentation Deck | 80 slidesKering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Return with Elixir1 hit
01
Slide 1
Includes company logo and date.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Attention1 hit
08
The slide uses a biological pathway diagram to illustrate the mechanism of action for a drug candidate.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
18
The slide provides clinical safety data for the KT-474 drug candidate.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
20
Includes clinical trial identifiers and definitions of acronyms in the footer.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
29
The table tracks clinical trial outcomes (PR: Partial Response, SD: Stable Disease, PD: Progressive Disease) for a drug candidate.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · Action1 hit